Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: The Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial

Hypertension Research

Volumn 27, Issue 3, 2004, Pages 181-191

  Yui, Yoshiki ^a   Sumiyoshi, Tetsuya ^b   Kodama, Kazuhisa ^c   Hirayama, Atsushi ^c   Nonogi, Hiroshi ^d   Kanmatsuse, Katsuo ^e   Origasa, Hideki ^f   Iimura, Osamu ^g   Ishii, Masao ^h   Saruta, Takao ⁱ   Arakawa, Kikuo ^j   Hosoda, Saichi ^b   Kawai, Chuichi ^k  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b SAKAKIBARA HEART INSTITUTE   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOYAMA   (Japan)

^g Sapporo General Hospital of Hokkaido Railway Company   (Japan)

^h Yokohama Seamen's Hospital   (Japan)

ⁱ KEIO UNIVERSITY HOSPITAL   (Japan)

^j FUKUOKA UNIVERSITY   (Japan)

^k TAKEDA GENERAL HOSPITAL   (Japan)

more..

Author keywords

Angiotensin converting enzyme inhibitor; Antihypertensive agents; Coronary artery disease; Nifedipine retard

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUNAZOSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; IMIDAPRIL; LISINOPRIL; NIFEDIPINE; PRAZOSIN;

AGED; ANGINA PECTORIS; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUGHING; DRUG EFFICACY; DRUG FATALITY; ECG ABNORMALITY; EDEMA; ERYTHEMA; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; GINGIVA HYPERTROPHY; HEADACHE; HEALTH CARE FACILITY; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE FIBRILLATION; HOSPITALIZATION; HOT FLUSH; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; JAPAN; KAPLAN MEIER METHOD; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALAISE; MALE; METHODOLOGY; MORTALITY; MULTICENTER STUDY; OPEN STUDY; OUTPATIENT DEPARTMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NIFEDIPINE;

EID: 11144355108     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.181     Document Type: Article

References (29)

1. Pristipino C, Beltrame J, Finocchiaro, ML, et al: Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
2. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension: Guidelines for the management of hypertension for general practitioners. Hypertens Res 2001; 24: 613-634.
3. The GLANT Study Group: A 12-month comparison of ACE inhibitor and Ca antagonist therapy in mild to moderate essential hypertension. Hypertens Res 1995; 18: 235-244.
4. Hasebe N, Kido S, Ido A, Kikuchi K: Angiographical Study in Angina with Hypertension Induced Insults (ASAHI) Investigators; reverse J-curve relation between diastolic pressure and severity of coronary artery lesion in hypertensive patients with angina pectoris. Hypertens Res 2002; 25: 381-387.
5. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium-channel blockers vs. diuretic. JAMA 2002; 288: 2981-2997.
6. Hurst JW, Walter PF, King III SB, Morris DC, Friesinger GC: Atherosclerotic coronary heart disease: recognition, prognosis, and treatment, in Hurst JW (eds): The Heart, 6th ed. New York, McGraw Hill, 1985, pp 888-907.
7. Struss HW, Harrison K, Langan JK, Lebowrrz E, Pitt B: Thallium-201 for myocardial imaging: relation of thallium-201 to regional myocardial perfusion. Circulation 1975; 51: 641-645.
8. Reiss C, Eisenberg P: Ischemic heart disease, in Woodley M, Whelan A (eds): Manual of Medical Therapeutics, 26th ed, Boston, Little, Brown and Co., 1990, pp 79-85.
9. Hansson L, Hender T, Dahlof B: Prospective randomized open blinded endpoint (PROBE) study: a novel design for intervention trials. Blood Press 1992; 1: 113-119.
10. Hansson L, Zanchetti A, Carruthers SG, et al: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment(HOT) randomized trial. Lancet 1998; 351: 1755-1762.
11. Hansson L, Lindholm LH, Niskanen L, et al: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999; 353: 611-616.
12. Yoshitoshi Y, Kaneko Y, Saruta T: Antihypertensive effect of MK-421 (enalapril maleate) with concomitant thiazide diuretics in patients with essential hypertension: multiclinic pilot, open study. Jpn Pharmacol Ther 1984; 12: 3439-3468 (in Japanese).
13. Saruta T, Omae T, Iimura O, et al: Efficacy and safety of imidapril (ACE/TA-6366), angiotensin I converting enzyme inhibitor, in monotherapy on essential hypertension-multiclinic open study. Rinsho Igaku 1991; 7: 2485-2504 (in Japanese).
14. Arakawa K, Iimura O, Yoshinaga K, et al: Antihypertensive effect of lisinopril (MK-521) in essential hypertension: result of a multiclinic open trial. Saishin Igaku 1990; 45: 834-858 (in Japanese).
15. Statistics and Information Department of Ministry of Health and Welfare: Vital Statistics of Japan: Trends in Death Rates by Sex, Age and Causes of Death 1992, Vol 1, pp 166-167 (in Japanese).
16. Hosoda S, Oino T, Yasuda H, et al: Long-term follow-up of medically treated patients with coronary artery disease: incidence of major cardiac events and its risk factors in Japanese with coronary artery disease. Jpn Circ J 1990; 54: 231-240.
17. The West of Scotland Coronary Prevention Study Group: A coronary primary prevention study of Scottish men aged 45-64 years: trial design. J Clin Epidemiol 1992; 45: 849-860.
18. Hollis S, Campbell F: What is meant by intention to treat analysis?: survey of published randomised controlled trials. BMJ 1999; 319: 670-674.
19. Psaty BM, Heckbert SR, Koepsell TD, et al: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-625.
20. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-1331.
21. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with noninsulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645-652.
22. Schrier RW, Estacio RO: Additional follow-up from the ABCD Trial in patients with type 2 diabetes and hypertension. N Engl J Med 2000; 343: 1969.
23. Tatti P, Pahor M, Byington RP, et al: Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998; 21: 597-603.
24. Hansson L, Lindholm L, Ekbom T, et al: Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovasucular mortality and morbidity the Swedish trial in old patients with hypertension-2 study. Lancet 1999; 354: 1751-1756.
25. Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000; 356: 1955-1964.
26. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-1315.
27. Clinical Evaluation of Antihypertensive Drugs Group: Proposed guidelines for the clinical evaluation of antihypertensive drugs. Drug Res 1979; 10: 849-864 (in Japanese).
28. Baba S, The J-MIND Study Group: Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics. Diabetes Res Clin Practice 2001; 54: 191-201.
29. Kazumi T, Kikkawa R, Yoshino G, Nakashima M, Origasa H, Baba S: Long-term effect of nifedipine retard versus enalapril therapy on the incidence of cardiovascular events in hypertensive type 2 diabetic patients. Eur Heart J 2000; 2 (Suppl D): 33-34.